How much will I have to pay if you reship the product?
We will reship the product free of charge. No additional charges will be placed.
USP Chief Science Officer Darrell Abernethy To Receive ACCP Distinguished Service Award
The U.S. Pharmacopeial (USP) Convention is pleased to announce that its chief science officer, Darrell Abernethy, M.D., Ph.D., will be honored with the American College of Clinical Pharmacology's (ACCP) Nathaniel T. Kwit Memorial Distinguished Service Award at the 2008 ACCP Annual Meeting in Philadelphia, Pa., September 14-16. Dr. Abernethy is being recognized for his lasting contributions to cardiovascular clinical pharmacology. As chief science officer of USP, Dr.
By 2012, Legitimate Generics Will Account For 20% Of Brazil's Pharmaceuticals And Healthcare Market
Research and Markets has announced the addition of the "Brazil Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The "Brazil Pharmaceuticals and Healthcare Report" provides independent forecasts and competitive intelligence on Brazils pharmaceuticals and healthcare industry. Brazil's pharmaceutical market remains one of the bright spots globally, having posted 17.0% growth in 2007 and reaching an estimated value of US$12.9bn in final consumer prices.
Patent System For Drugs 'Morally Unacceptable'
Major drugs companies are using fierce lobbying tactics to protect a pharmaceutical patent system that is "simply morally unacceptable", a world-leading political philosopher told a major meeting of UK and European pharmacologists.
European Biotech Industry Identifies The Real Culprits Causing Food Price Rises
The European Biotech Industry Association (EuropaBio) questions the premises and the methods used by recent reports, including the recently leaked and unofficial World Bank internal note which claims that 75% of the recent price increase of food is due to increasing demand for biofuel.
SEM Thought-Leaders To Gather For Eyeforpharma's Search Engine Marketing Summit 2008
eyeforpharma has announced the launch of the premier pharmaceutical Search Engine Marketing Event on October 22nd in Boston. The conference has been highly anticipated and in a sneak preview of the agenda, Gerard Moore, the Event Producer, has announced that the following Search experts will be speaking at the event.
U.S. Investigating Indian Pharmaceutical Company Ranbaxy Over Generic Drugs, Including Antiretrovirals Used In PEPFAR
U.S. investigators are looking into whether Indian pharmaceutical company Ranbaxy Laboratories manufactured substandard generic drugs, including HIV/AIDS medications provided to thousands of HIV-positive people in Africa, the Wall Street Journal reports. Ranbaxy under a U.S. government contract was paid "millions of dollars" to provide low-cost antiretroviral drugs under the
Pharma Sales Executives Meet At Annual Summit To Exchange Sales Force Effectiveness Best-Practice, Network
The Russian-CIS pharmaceutical market is exploding. PriceWaterhouseCooper records suggest that the Russian Pharmaceutical market is growing by over 1/3 every year. This growth creates new challenges. How do you make your Sales Force more effective and not just larger to ensure long-term success? The Sales Force Effectiveness Summit, October 7-8, Moscow, addresses these issues head-on and presents best practices in meeting these challenges.
44th Annual Meeting Is Largest Event In Drug Information Association History
The Drug Information Association has announced that the 44th Annual Meeting, held from June 22-26 in Boston, Massachusetts, was the largest event in the association's more than 40-year history. "This year we received the largest ever number of abstracts for the Annual Meeting," notes Annual Meeting Program Chair Jeffrey Sherman, MD, FACP.
Roche To Stop Antiretroviral Research, Company Says
Pharmaceutical company Roche in a memo circulated last week announced that it will stop research on antiretroviral drugs because of "disappointing results in clinical trials," the Financial Times reports.
Australian Discovery First Step To New Therapies
In an Australian first, scientists at Sydney's Centenary Institute have mapped the anatomy of a membrane protein. This exciting discovery has the potential to turn the way we discover new drugs on its head and reduce the development time for new treatments. "These membrane proteins are the target for 70% of all therapeutic drugs so an increased understanding of them is vital for future drug discoveries," said Centenary Institute Executive Director, Professor Mathew Vadas.
Company Suspended From ABPI Membership Over Breaches Of Code Of Practice
Roche Pharma in the UK has been suspended from membership of the Association of the British Pharmaceutical Industry (ABPI) for a minimum of six months in connection with serious breaches of the ABPI Code of Practice, it was announced today. The action is as a result of activities between 2003 and 2005 held to be in breach of the Code, including Clause 2 which deals with actions likely to bring discredit on, or reduce confidence in, the pharmaceutical industry.
PhRMA Announces Revised Voluntary Guidelines To Prohibit Gifts To Physicians
Pharmaceutical Research and Manufacturers of America on Thursday released revised voluntary marketing guidelines that ban gifts from pharmaceutical companies to physicians, Bloomberg/Indianapolis Star reports (Bloomberg/Indianapolis Star, 7/11).
NIH Fails To Oversee Grantees' Conflicts Of Interest, Grassley Says
NIH has failed to oversee conflicts of interest relating to almost $24 billion in annual funds the agency distributes to outside organizations for medical research, according to a recent letter by Sen. Chuck Grassley (R-Iowa) to the Senate Appropriations Committee,
Cancer Drug Reformulation Featured In Prestigious Journal
Dr. Yuri Lvov, a professor of chemistry and T. Pipes endowed chair in micro and nanosystems at Louisiana Tech University, and Anshul Agarwal, a Louisiana Tech doctoral candidate in biomedical engineering feature their cancer drug reformulation work in the most recent issue of Pharma Focus Asia, one of the largest and most respected pharmaceutical science journals in the world.
Op Jaipur Nets Estimated Seizure Of 20,000 Sex Drugs In Wokingham
Enforcement officers from the Medicines and Healthcare products Regulatory Agency (MHRA), together with assistance from Thames Valley Police, have seized approximately 20,000 unlicensed medicines, worth an estimated £50,000. The medicines seized consisted of Kamagra tablets and jellies, used for male impotence. The result came following an early morning visit, codenamed Op Jaipur, by MHRA enforcement officers and police to three addresses in the Wokingham and Bracknell area.
BIO Welcomes PhRMA's Revised Code On Interactions With Healthcare Professionals
BIO President and CEO Jim Greenwood issued the following statement following the release of the Pharmaceutical Research and Manufacturers of America (PhRMA) revised Code on Interactions with Healthcare Professionals: "As public dialogue continues over the proper ethical standards gui
Access To Medication Improved By Integrated Tube Cap Design
Many vitamin pills and tablets such as pain killers are packaged today in cylindrical tubes with a cork-like cap. This will often incorporate some form of desiccant to protect the contents against moisture, while a simple mechanical spring in the tube stops the contents from rattling around. However, such caps often fall off, are easy to lose and require two hands to manipulate.
Senator Herb Kohl Reacts To Release Of PhRMA'S New Code Of Conduct
U.S. Senator Herb Kohl (D-WI), Chairman of the U.S. Special Committee on Aging, reacted to the release of a new voluntary code of conduct by the Pharmaceuticals Research and Manufacturers Association (PhRMA), the drug industry's foremost trade association. Kohl is behind several initiatives to force greater transparency in the way drug companies interact with doctors, in an effort to curb spiraling prescription drug costs.
PhRMA Revised Marketing Code Reinforces Commitment To Responsible Interactions With Healthcare Professionals
Reflecting the continuing commitment of America's pharmaceutical research and biotechnology companies to pursue policies and practices that best serve the needs of patients and the healthcare community, the Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors has adopted measures to enhance the PhRMA Code on Interactions with Healthcare Professionals. The newly revised
FDA Revises Process For Responding To Drug Applications
The U.S. Food and Drug Administration announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted. Under new regulations that govern the drug approval process, FDA's Center for Drug Evaluation and Research (CDER) will no longer issue "approvable" or "not approvable" letters when a drug application is not approved.
GOOD Day!!
Just to tell you the package arrived TODAY !!!
i RECEVED THE MISSING PACKAGE TODAY AND THE THE ADDED GIFT. (--> Thanks!)
i WANT TO THANK YOU VERY MUCH FOR YOUR EXCELLENT FOLLOW UP AND CUSTOMER SERVICE!
You are a very impressive company and I will surely pass the higest recommendation to my associates and friends.
Thanks again for your fast solutioin, As I am also in customer serivce, I really appreciate the care you have given , and promise to do the same to my customers.
- Mark
USP Chief Science Officer Darrell Abernethy To Receive ACCP Distinguished Service Award
The U.S. Pharmacopeial (USP) Convention is pleased to announce that its chief science officer, Darrell Abernethy, M.D., Ph.D., will be honored with the American College of Clinical Pharmacology's (ACCP) Nathaniel T. Kwit Memorial Distinguished Service Award at the 2008 ACCP Annual Meeting in Philadelphia, Pa., September 14-16. Dr. Abernethy is being recognized for his lasting contributions to cardiovascular clinical pharmacology. As chief science officer of USP, Dr.
